We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBTYK icon
476
Liberty Global Class C
LBTYK
$3.56B
$2.93K ﹤0.01%
164
-50
-23% -$871
KOMP icon
477
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.67B
$2.83K ﹤0.01%
61
HPQ icon
478
HP
HPQ
$27.5B
$2.8K ﹤0.01%
80
SLYV icon
479
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
$2.77K ﹤0.01%
35
TMUS icon
480
T-Mobile US
TMUS
$195B
$2.64K ﹤0.01%
15
LRGF icon
481
iShares US Equity Factor ETF
LRGF
$3.71B
$2.62K ﹤0.01%
47
FNDC icon
482
Schwab Fundamental International Small Company Index ETF
FNDC
$3.18B
$2.61K ﹤0.01%
75
GEM icon
483
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.75B
$2.52K ﹤0.01%
77
DVY icon
484
iShares Select Dividend ETF
DVY
$23.8B
$2.42K ﹤0.01%
20
FNDA icon
485
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$2.31K ﹤0.01%
84
AVB
486
DELISTED
AvalonBay Communities
AVB
$2.28K ﹤0.01%
11
FLO icon
487
Flowers Foods
FLO
$1.51B
$2.22K ﹤0.01%
100
FEM icon
488
First Trust Emerging Markets AlphaDEX Fund
FEM
$810M
$2.15K ﹤0.01%
90
SRCE icon
489
1st Source
SRCE
$2.08B
$2.02K ﹤0.01%
38
UNM icon
490
Unum
UNM
$14.7B
$1.95K ﹤0.01%
38
BBEU icon
491
JPMorgan BetaBuilders Europe ETF
BBEU
$9.48B
$1.94K ﹤0.01%
33
NLY icon
492
Annaly Capital Management
NLY
$17.4B
$1.91K ﹤0.01%
100
-122
-55% -$2.37K
BAM icon
493
Brookfield Asset Management
BAM
$83.2B
$1.9K ﹤0.01%
50
HST icon
494
Host Hotels & Resorts
HST
$15.3B
$1.8K ﹤0.01%
100
-6
-6% -$112
GSIE icon
495
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.12B
$1.72K ﹤0.01%
51
EWW icon
496
iShares MSCI Mexico ETF
EWW
$1.77B
$1.7K ﹤0.01%
30
BGS icon
497
B&G Foods
BGS
$286M
$1.7K ﹤0.01%
210
HPE icon
498
Hewlett Packard
HPE
$69.3B
$1.69K ﹤0.01%
80
RIVN icon
499
Rivian
RIVN
$23.3B
$1.68K ﹤0.01%
125
OIH icon
500
VanEck Oil Services ETF
OIH
$1.99B
$1.58K ﹤0.01%
5

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.